Innoscience (02577.HK) Races to Profitability Amidst Double Celebration

ZC Asia has learnt that on 3 December, Innosea Technology (02577.HK) secured a partial victory in its patent litigation against Infineon Technologies at the United States International Trade Commission (ITC). Regarding the two patents in dispute, Innosea was found to be in no way infringing one of them, while its design around the other was also deemed non-infringing.

On the same day, the company also announced a high-profile strategic partnership with ON Semiconductor to jointly advance the application of gallium nitride in new energy vehicles, AI and other fields.

However, for a semiconductor company whose core metrics remain loss-making, whether clearing legal hurdles and partnering with industry giants can truly translate into sustainable profitability remains a question hanging over its head.

Significant Growth Amid Persistent Losses

In the first half of 2025, Innosea achieved sales revenue of RMB 553 million, representing a 43.4% year-on-year increase. This continues the company's sustained pattern of rapid growth over multiple years. Its gross margin improved from -21.6% in the same period last year to +6.8%, marking the company's first-ever positive gross profit.

This improvement primarily stemmed from optimised product mix and process platform upgrades. Revenue from GaN module operations reached RMB 236 million, surging 121.7% year-on-year, while revenue from lower-tech GaN wafers declined by 22.2%.

Nevertheless, Innoscience continues to grapple with substantial loss pressure. The net loss for the first half of 2025 stood at RMB 428 million, narrowing from RMB 488 million in the same period last year, yet the deficit remains substantial.

As of 30 June 2025, Innoscience held cash and cash equivalents of RMB 1.425 billion, but total loans and borrowings reached RMB 2.495 billion, with new borrowings amounting to RMB 571 million during the half-year.

Although the company's current ratio improved from 2.5 times at the end of 2024 to 3.2 times, its net debt ratio rose from 13.4% at the end of last year to 40%.

Funding pressures manifest in two primary areas: Firstly, cash flow from operating activities remains persistently negative, standing at -RMB 336 million in 2024 and -RMB 387 million in the first half of 2025; Secondly, substantial capital investment is required to maintain technological leadership and support market expansion.

Excessive expenditure represents another significant challenge. During the first half of 2025, the combined proportion of sales, general and administrative expenses relative to revenue reached 54.1%. Notably, research and development expenditure accounted for nearly 30% of revenue, amounting to RMB 162 million, an 11.5% year-on-year increase.

The Balancing Act Between Technology and Competition

The gallium nitride semiconductor sector in which Innosea operates faces two core challenges: technological reliability and cost issues.

Particularly in industrial and automotive applications, higher demands are placed on device longevity and interference resistance. Simultaneously, despite process optimisations reducing some costs, gallium nitride products still carry a cost premium compared to traditional silicon devices.

The company must expand production scale and refine its supply chain to further reduce costs. As the industry's first to achieve mass production of 8-inch silicon-based GaN wafers, Innosea's technological leadership has secured it a certain market position.

However, competition is intensifying as global semiconductor giants increasingly enter the GaN market.

As GaN technology extends beyond consumer electronics into the automotive and industrial sectors demanding higher reliability, the core challenge for Innoscience remains whether its technological edge can be translated into sustained profitable commercial outcomes.

Disclaimer: The content herein is for reference only and does not constitute any form of investment advice. Should any information contained herein prove inaccurate, incomplete, or potentially misleading, please refer to the company's official announcements. Market risks exist; investment requires caution.